academic article

• Developing drugs for treatment of atopic dermatitis in children (≥3 months to <18 years of age): Draft guidance for industry..  Pediatric dermatology.  35:303-322. 2018
• Developing drugs for treatment of atopic dermatitis in children (≥3 months to <18 years of age): Draft guidance for industry..  Pediatric dermatology.  35:303-322. 2018
• Developing drugs for treatment of atopic dermatitis in children (≥3 months to <18 years of age): Draft guidance for industry..  Pediatric dermatology.  35:303-322. 2018
• Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. 2014